Cargando…
Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E
Moloney leukemia virus activated both the classical and alternative pathways of human complement. About 500,000 virions were required to detect activation of the classical pathway whereas 5,000 times as many virions were necessary to initiate the alternative pathway, indicating that in this system o...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1978
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2184190/ https://www.ncbi.nlm.nih.gov/pubmed/632750 |
_version_ | 1782145660015869952 |
---|---|
collection | PubMed |
description | Moloney leukemia virus activated both the classical and alternative pathways of human complement. About 500,000 virions were required to detect activation of the classical pathway whereas 5,000 times as many virions were necessary to initiate the alternative pathway, indicating that in this system only the former is of biological significance. Disruption of the virus with Triton X-100 destroyed its ability to initiate the alternative pathway without affecting its ability to activate the classical pathway. After ultracentrifugation of disrupted virus the active component could be recovered in the supernate and was isolated by isoelectric focusing in granulated gels. Sodium dodecyl sulfate-polyacrylamide gel electrophoretic and analysis and cyanogen bromide digestion studies revealed that the activity resided in a methionine-containing protein having a pI of 7.5 and a molecular weight of approximately equal to 15,000 daltons. The purified protein interacts strongly with Clq and efficiently activates Cl. RNase and lipolytic enzymes had no effect on the isolated protein but incubation with trypsin resulted in loss of activity. Enzymatic digestion studies of surface-labeled virus indicate that the active protein is a viral membrane protein. On the basis of these results it is concluded that the complement receptor of Moloney leukemia virus is the surface protein p15E. |
format | Text |
id | pubmed-2184190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1978 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21841902008-04-17 Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E J Exp Med Articles Moloney leukemia virus activated both the classical and alternative pathways of human complement. About 500,000 virions were required to detect activation of the classical pathway whereas 5,000 times as many virions were necessary to initiate the alternative pathway, indicating that in this system only the former is of biological significance. Disruption of the virus with Triton X-100 destroyed its ability to initiate the alternative pathway without affecting its ability to activate the classical pathway. After ultracentrifugation of disrupted virus the active component could be recovered in the supernate and was isolated by isoelectric focusing in granulated gels. Sodium dodecyl sulfate-polyacrylamide gel electrophoretic and analysis and cyanogen bromide digestion studies revealed that the activity resided in a methionine-containing protein having a pI of 7.5 and a molecular weight of approximately equal to 15,000 daltons. The purified protein interacts strongly with Clq and efficiently activates Cl. RNase and lipolytic enzymes had no effect on the isolated protein but incubation with trypsin resulted in loss of activity. Enzymatic digestion studies of surface-labeled virus indicate that the active protein is a viral membrane protein. On the basis of these results it is concluded that the complement receptor of Moloney leukemia virus is the surface protein p15E. The Rockefeller University Press 1978-03-01 /pmc/articles/PMC2184190/ /pubmed/632750 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E |
title | Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E |
title_full | Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E |
title_fullStr | Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E |
title_full_unstemmed | Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E |
title_short | Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E |
title_sort | lysis of oncornaviruses by human serum. isolation of the viral complement (c1) receptor and identification as p15e |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2184190/ https://www.ncbi.nlm.nih.gov/pubmed/632750 |